JP2023107883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023107883A5 JP2023107883A5 JP2023096692A JP2023096692A JP2023107883A5 JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5 JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- composition
- surgery
- glp
- parenteral nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762582055P | 2017-11-06 | 2017-11-06 | |
| US62/582,055 | 2017-11-06 | ||
| JP2020526107A JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Division JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023107883A JP2023107883A (ja) | 2023-08-03 |
| JP2023107883A5 true JP2023107883A5 (cg-RX-API-DMAC7.html) | 2024-03-06 |
| JP7752152B2 JP7752152B2 (ja) | 2025-10-09 |
Family
ID=66332372
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
| JP2023096692A Active JP7752152B2 (ja) | 2017-11-06 | 2023-06-13 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11660328B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3706774A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7296958B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102825098B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111629745A (cg-RX-API-DMAC7.html) |
| AR (1) | AR113835A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018360744A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020008936A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3079523A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL274098B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020004620A (cg-RX-API-DMAC7.html) |
| TW (1) | TW201922279A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019090209A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202002080B (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111182916A (zh) * | 2017-08-22 | 2020-05-19 | 夏尔-Nps医药品有限公司 | Glp-2融合多肽及用于治疗及预防胃肠病状的用途 |
| JP2022512688A (ja) * | 2018-10-24 | 2022-02-07 | シャイア－エヌピーエス ファーマシューティカルズ インコーポレイテッド | Ｇｌｐ－２融合ポリペプチドならびに消化管の状態の処置および予防のための使用 |
| KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
| CA3173731A1 (en) | 2020-02-28 | 2021-09-02 | Kallyope, Inc. | Gpr40 agonists |
| WO2021198196A1 (en) * | 2020-03-30 | 2021-10-07 | Zealand Pharma A/S | Glp-1/glp-2 dual agonists |
| CA3178994A1 (en) | 2020-05-19 | 2021-11-25 | Iyassu Sebhat | Ampk activators |
| WO2021263040A1 (en) * | 2020-06-26 | 2021-12-30 | Shire-Nps Pharmaceuticals, Inc. | Stable peptibody formulations |
| WO2021263039A1 (en) | 2020-06-26 | 2021-12-30 | Kallyope, Inc. | Ampk activators |
| CN115636876A (zh) * | 2021-07-20 | 2023-01-24 | 重庆派金生物科技有限公司 | 胰高血糖素样肽-2突变体的定向化学偶联物及其应用 |
| CN117467025B (zh) * | 2023-12-28 | 2024-04-16 | 上海鼎新基因科技有限公司 | 一种抗vegf和补体双功能融合蛋白及其应用 |
| WO2025181330A1 (en) * | 2024-02-29 | 2025-09-04 | Vectivbio Ag | Dosage regimens for glucagon-like peptide 2 (glp-2) analogs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5197012B2 (ja) | 2004-11-01 | 2013-05-15 | エヌピーエス ファーマシューティカルズ インコーポレイテッド | 大腸連続性を伴う短腸症候群患者の治療 |
| CA2616551A1 (en) | 2005-07-29 | 2007-02-15 | Amprotein Corporation | Chimeric therapeutic agents |
| WO2007067828A2 (en) * | 2005-10-24 | 2007-06-14 | Centocor, Inc. | Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| EP2076604A4 (en) | 2006-08-31 | 2009-09-02 | Centocor Ortho Biotech Inc | GLP-2 MIMIC BODIES, POLYPEPTIDES, COMPOSITIONS, PROCESSES AND USES |
| JP2008247789A (ja) | 2007-03-30 | 2008-10-16 | Kissei Pharmaceut Co Ltd | クローン病に伴う腸管狭窄の進展抑制用医薬組成物 |
| EP2755675B1 (en) | 2011-09-12 | 2018-06-06 | Amunix Operating Inc. | Glucagon-like peptide-2 compositions and methods of making and using same |
| US9458214B2 (en) * | 2011-09-26 | 2016-10-04 | Novartis Ag | Dual function fibroblast growth factor 21 proteins |
| KR101895047B1 (ko) | 2011-12-30 | 2018-09-06 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체 |
| WO2013164484A1 (en) | 2012-05-03 | 2013-11-07 | Zealand Pharma A/S | Glucagon-like-peptide-2 (glp-2) analogues |
| WO2015095684A1 (en) * | 2013-12-20 | 2015-06-25 | Indiana University Research And Technology Corporation | Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides |
| KR101825048B1 (ko) | 2014-12-31 | 2018-02-05 | 주식회사 제넥신 | GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도 |
-
2018
- 2018-11-05 WO PCT/US2018/059175 patent/WO2019090209A1/en not_active Ceased
- 2018-11-05 JP JP2020526107A patent/JP7296958B2/ja active Active
- 2018-11-05 BR BR112020008936-2A patent/BR112020008936A2/pt unknown
- 2018-11-05 EP EP18872377.9A patent/EP3706774A4/en active Pending
- 2018-11-05 AU AU2018360744A patent/AU2018360744A1/en not_active Abandoned
- 2018-11-05 US US16/761,606 patent/US11660328B2/en active Active
- 2018-11-05 CA CA3079523A patent/CA3079523A1/en active Pending
- 2018-11-05 KR KR1020207013387A patent/KR102825098B1/ko active Active
- 2018-11-05 IL IL274098A patent/IL274098B2/en unknown
- 2018-11-05 MX MX2020004620A patent/MX2020004620A/es unknown
- 2018-11-05 CN CN201880071791.3A patent/CN111629745A/zh active Pending
- 2018-11-06 TW TW107139266A patent/TW201922279A/zh unknown
- 2018-11-06 AR ARP180103232A patent/AR113835A1/es unknown
-
2020
- 2020-05-04 ZA ZA2020/02080A patent/ZA202002080B/en unknown
-
2023
- 2023-06-13 JP JP2023096692A patent/JP7752152B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023107883A5 (cg-RX-API-DMAC7.html) | ||
| Acharya et al. | Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial | |
| IL274098B2 (en) | Glp-2 analogs and peptibodies for administration before during, or after surgery | |
| Lever | Methotrexate and prednisone in pemphigus vulgaris: therapeutic results obtained in 36 patients between 1961 and 1970 | |
| Bywaters | Heel lesions of rheumatoid arthritis | |
| Buchwald et al. | Ileal bypass in patients with hypercholesterolemia and atherosclerosis: preliminary report on therapeutic potential | |
| Sharma et al. | Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies | |
| JP2021502389A5 (cg-RX-API-DMAC7.html) | ||
| Halloun et al. | Bariatric surgery in adolescents with obesity: long-term perspectives and potential alternatives | |
| JP2019112416A5 (cg-RX-API-DMAC7.html) | ||
| JP2019530648A5 (cg-RX-API-DMAC7.html) | ||
| Gray | Treatment of advanced head and neck cancer with accelerated fractionation | |
| Zemskov et al. | Efficacy of Ukrain in the treatment of pancreatic cancer | |
| Pelz et al. | A case of pre-chronic paroxysmal hemicrania | |
| Tham et al. | Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer | |
| Ozaki et al. | Manifestation of latent left ventricular outflow tract obstruction caused by acute myocardial infarction: an important complication of acute myocardial infarction | |
| Chin et al. | Cerebellar glioblastoma in childhood | |
| Boland | V. Clinical Experience with Nitrogen Mustard in Hodgkin's Disease | |
| Matijević et al. | Early reconstruction of bone defect created after initial surgery of a large keratocystic odontogenic tumor: A case report | |
| Hanna et al. | Efficacy and complications of intravesical BCG in immunocompromised patients | |
| Kaddioui et al. | Pansclerotic morphea: a historical case in children | |
| Greenberg et al. | Current and emerging multiple sclerosis therapeutics | |
| Elbrønd et al. | Circinoma Linguae: A series of 96 patients | |
| Haque et al. | Oral Propranolol and Prednisolone in the Treatment of Infantile Hemangioma: A Comparative Study | |
| Akhyar et al. | Clinical features and evaluation of systemic sclerosis: A dermatology-based case series |